aim of the present study was to determine the relative sensitivity of the full pyruvate tolerance test and the red blood cell transketolase activation in detecting vitamin Br deficiency in patients admitted to hospital for alcohol abuse and to test recent suggestions (Baron, 1973; Whitby et al., 1975) that red blood cell transketolase activity appears to be the method of choice for investigating possible thiamine deficiency. The two indices of vitamin Bi status described above, together with indices of vitamins B2 and B6 and the measurement of leucocyte vitamin C, formed the assessment of the vitamin status of the patients under study in order to determine which of the vitamins are most commonly deficient. Finally, an attempt was made to correlate the degree of deficiency with the exposure to alcohol, as indicated by the serum activity of y-glutamyl transferase, an enzyme known to be induced by alcohol intake (Rosalki and Rau, 1972) and to be of significance as a test of hepatic injury in the alcohol abuser (Boone et al., 1977) . SUMMARY The activity of the red blood cell enzymes transketolase, glutathione reductase, and aspartate transaminase, and their activation by the coenzymes thiamine, riboflavin, and pyridoxine, the pyruvate tolerance test, the leucocyte vitamin C concentration, and the activity in serum of yglutamyl transferase were measured in a series of 35 patients with alcohol-related illness. The
incidence of thiamine deficiency was 31 %as assessed by the activation of transketolase, and 55 %as assessed by the pyruvate tolerance test. The incidence of riboflavin deficiency was 23 % and of ascorbic acid deficiency 91 %. No cases of pyridoxine deficiency were detected.
The pyruvate tolerance test was found to be a more sensitive test of thiamine deficiency than the transketolase activation, and the activation of red blood cell aspartate transaminase was found to be a poor indicator of pyridoxine deficiency. There was a poor correlation of the y-glutamyl transferase activity with the degree of vitamin deficiency, suggesting that alcohol exposure is only partly responsible for the observed vitamin deficiency.
The possibility of detecting B vitamin deficiency in a hospital population has recently become a more feasible proposition with the introduction of methods involving measurement of red blood cell enzyme activity with and without their co-enzyme activators. Thus indices of vitamin Bi, B2,and B6 status can be obtained by measuring red blood cell transketolase (TK, E.C. 2.2. 1.1) with and without thiamine pyrophosphate, red blood cell glutathione reductase (GR, E.C. 1.6. 4.2) with and without flavin adenine dinucleotide, and red blood cell aspartate transaminase (AST, E.C. 2.6. 1.1) with and without pyridoxal phosphate (Bayoumi and Rosalki, 1976) . A more traditional approach to the identification of thiamine deficiency, a possible cause of neurological disorders such as peripheral neuropathy in the alcoholic, has been the response of blood pyruvate to a glucose load, the so-called 'pyruvate tolerance test'. In the absence of its co-enzyme, thiamine pyrophosphate, transketolase is inactivated, and the metabolism of pyruvate, formed from glucose, is impaired. The pyruvate tolerance test has been used by Materials and methods Morgan (1968) to detect thiamine deficiency in two groups of chronic alcoholics, those experiencing SUBJECTS hallucinations and those with no such symptoms. A group of 35 patients admitted to hospital for the Cambier et al. (1973) have compared a single estima-treatment of problems associated with alcohol abuse tion of pyruvic acid with a colorimetrically deter-was studied. As far as was possible all such hospital mined transketolase level as an index of thiamine admissions over a 15-monthperiodwereincluded. The status in patients with neurological disorders. The reasons for hospitalisation included peripheral 307 neuritis and paresthesiae and ethanolic liver damage. Five patients were subsequently shown histologically to have developed cirrhosis. As it was not possible to determine the degree of alcohol dependence the term 'alcoholic', implying alcohol dependence, has been avoided. The group probably included those described as 'heavy drinkers' and 'alcoholics' by Rosalki and Rau (1972) . A group of 21 healthy laboratory staff, age range 18-55, formed a reference population for the red blood cell enzyme studies. The control group for the pyruvate studies was composed of 15 subjects of age range 25-60 years. The population included laboratory staff and hospital inpatients who were due for discharge in an adequately fit and nourished condition. No subject in the control group had, as far as was known, any illness likely to affect the metabolism of glucose or any known vitamin deficiency.
EXPERIMENTAL METHODS

Red blood cell enzymes
These were measured in an haemolysate prepared as follows. A 5-10 mI blood sample was collected into a tube containing lithium heparin, centrifuged at 3000 rpm for 10 minutes and the plasma and buffy coat removed. The cells were then washed twice with an equal volume of saline (NaCI, 9 g/l) and finally mixed with a further equal volume of saline before being frozen at -20°C. For assay the following day, or within two days of being taken, the cells were haemolysed by thawing and centrifuged at 3000 rpm for 10 minutes to remove cell debris, and O'5 mI of the haemolysate was mixed with 1·0 mI of saline. This dilution provided a final haemoglobin concentration of approximately 50 g/I for the measurement of transketolase activity. A further dilution of 0·5 mlof the above mixture with 2·0 mI of saline was prepared for the measurement of glutathione reductase and aspartate transaminase. The haemoglobin content of the haemolysate was measured by the cyanrnethaemoglobin method described by Henry et al. (1974) . The materials and methods used for the estimation of the blood cell enzyme activities were essentially those described by Bayoumi and Rosalki (1976) , except that all measurements were made at 37°C. A Beckman Model 25 Spectrophotometer with attached Recorder/Controller Unit (Beckman-RIIC Ltd, Gienrothes, Fife, Scotland) was used for the measurements.
Pyruvate measurement
Blood samples for pyruvate estimation were obtained from an antecubital vein of the supine patient, using minimum stasis and without fist-clenching (Braybooke et al., 1975) . The first sample was M. Baines obtained after an overnight fast and further specimens at 30, 60, and 120 minutes after an oral dose of 50 g glucose. Blood (4 ml) was immediately mixed with 4 mI of ice-cold perchloric acid (1M) to prevent further metabolism of the pyruvate. After centrifugation, the pyruvate in the supernatant fluid was measured enzymatically at 340 nm by the method of Czok and Lamprecht (1970) .
Leucocyte vitamin C
This was measured on blood (8 ml), collected into a tube containing lithium sequestrene as anticoagulant, by the method of Denson and Bowers (1961) . The reference range for an adult population in this laboratory is 114-342 nmol/lO B WBC.
y-Glutamyl transferase
The activity in serum of y-glutamyl transferase (E.C. 2.3. 2.2) was measured at 37°C by the method of Rosalki and Tarlow (1974) except that the final concentrationofthe substrate (y-glutamyl-p-nitroanilide) was reduced to 3·2 mM as suggested by Tarbit (1975) and recommended by the Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (1976) . The measurements were made on a Gilford 3400 Enzyme Analyser (Gilford Instruments Ltd, Teddington, Middlesex). The reference ranges for an adult population in this laboratory are up to 45 U/I for female subjects and up to 48 U/I for male subjects. Table 1 shows the red blood cell enzyme activity and percentage activation by the co-enzymes in a reference population of 21 laboratory workers (16 men and five women not taking oral contraceptives, age range 18-55 years). The results are in broad agreement with those obtained by Bayoumi and Rosalki (1976) but differ for the enzymes glutathione reductase and aspartate transaminase from those described by Williams (1976) . Table 2 shows the fasting pyruvate level and the response to a 50 g glucose load in a reference population of 15 subjects, age range 25-60 years. The values obtained from this population are compared with those described by Landon et al. (1962) , who used a glucose dose of 1 g/kg body weight, and by Whitby et al. (1975) , whose figures were based on a 100 g glucose dose. From the data presented in Table 2 it was decided that the criteria of abnormality of a pyruvate tolerance test would be a fasting pyruvate level of greater than 104 fLmolfl together with a 60minute level greater than 128 fLmol/l, or a single 60minute level of greater than 128 fLmol/l. The latter criterion would accommodate those patients who, although having a normal fasting pyruvate level, were unable to respond in a normal manner to a glucose load.
Results
The levels of y-glutamyl transferase activity, the leucocyte vitamin C level, and the incidence of pyruvate tolerance test and red blood cell enzyme abnormality in the population under study are shown in Table 3 , and Table 4 summarises the relationship between the two indices of thiamine deficiency. It can be seen from Table 3 that the pyruvate tolerance test was abnormal in 18 out of 33 cases (an incidence of 55 %), the transketolase activation was abnormal in 11 of 35 cases (31 %),the glutathione reductase activation was abnormal in The alcohol abuser is at risk of becoming thiaminedeficient for a number of reasons, including neglect of eating habits, impaired absorption of thiamine (Baker et al., 1975) , and impaired utilisation of thiamine due to decreased phosphorylation by a damaged liver. The signs of deficiency may be subclinical, yet treatment is readily available and the response is usually good in the absence of severe cirrhosis. Estimates of thiamine in blood or urine, using chemical (Johnson et al., 1945) or microbiological methods (Baker and Frank, 1968) , are tedious and unsuitable for the routine laboratory and may not give a true indication of tissue stores. The potential advantages of obtaining indices of three B vitamins from a single, small sample of erythrocytes from a non-fasted patient are obvious and look attractive when compared with the need in the pyruvate tolerance test to fast the patient overnight, administer glucose, and obtain four venous samples over two hours. Yet it can be seen from Table 3 that the incidence of pyruvate test abnormality (55 %) is considerably greater than that of transketolase activation abnormality (31 %), and therefore if the pyruvate response to a glucose load is a true indication of thiamine status then that test would appear to be a more sensitive indicator of thiamine deficiency than the transketolase activation. Both tests are, however, only indirect estimates of the thiamine level and may be influenced by conditions other than that of pure thiamine deficiency. The pyruvate level is known to be affected by diseases such as diabetes mellitus, congestive heart failure, and some digestive disorders, but, as far as was known, none of the patients under study was suffering from these disorders. Liver disease will, of course, affect both the pyruvate level and the transketolase activation by reducing the phosphorylation of thiamine and the production of the apoenzyme of transketolase, but both tests should be affected in a similar manner, depending upon the degree of liver damage. Indeed, of the group of five patients with cirrhosis in this series, two patients had abnormality in both pyruvate tolerance test and transketolase activation, two patients had abnormality in neither, and one patient had abnormality of pyruvate tolerance test only. Further evidence that both the pyruvate tolerance test and transketolase activation may be regarded as indicative of the thiamine status is that both tests responded to thiamine replacement therapy. In two patients who were given large intramuscular doses of thiamine hydrochloride over 10 days (Parentrovite IMRP, Bencard, Brentford, Middlesex TW8 9BE) the 6O-minute pyruvate level fell from 168 p.mol/l to 104 p.mol/l and the transketolase activation from 25'6% to 0% in one (patient LT, no. 16) and from 183 p.mol/l to 119 p.mol/land 29·8 %to 0% in the second (patient MK, no. 3). It may be concluded, therefore, that both the pyruvate tolerance test and the activation of transketolase are sensitive to the thiamine status of the body, but that, even though pyruvate is dependent for its further metabolism upon the pentose phosphate cycle, and thus the enzyme transketolase, the pyruvate test is a more sensitive indicator of thiamine deficiency than the activation of red blood cell transketolase.
M. Baines
Discussion
The incidence of vitamin B2 (riboflavin) deficiency, as assessed by the flavin activation of red blood cell glutathione reductase, was 23 % (8 of 35 cases), a slightly lower incidence than that of thiamine deficiency as detected by transketolase activation. In a smaller study, Bayoumi and Rosalki (1976) found an incidence of 15 %(2 of 13 cases), and in a population of geriatric patients Room et al. (1975) found an incidence of B2 deficiency of 11·7 % and of Bl deficiency of 22·9 %. Thus it appears that riboflavin deficiency is less prevalent than thiamine deficiency, which may be explained by the fact that riboflavin, unlike thiamine, is readily absorbed from food sources by the alcoholic (Baker et al., 1975) .
No cases of vitamin Be (pyridoxine) deficiency were found in the present series, in agreement with the small series of Bayourni and Rosalki (1976) . Indeed, from a total of 85 estimations done in this laboratory on a mixed hospital population (mainly geriatric and alcoholic) only one case of Bo deficiency has been discovered. Room et al. (1975) found an incidence of 19 % in geriatric patients. Vitamin Be deficiency has been noted in uraemic patients by measurement of the plasma pyridoxine level (Stone et al., 1975) , in women using oral contraceptives by measurement of blood pyridoxal phosphate (Shane and Contractor,1975 (Reinken et al., 1972) , and in 25 of 50 alcoholics by a microbiological measurement of pyridoxine (Davis and Smith, 1974) . A similar incidence (35 of 66 cases) of low plasma pyridoxal phosphate was noted in a series of alcoholic patients without abnormal liver findings by Lumeng and Li (1974) . Thus a biochemical deficiency of pyridoxine has been clearly established in the alcoholic population and is supported by the work of Baker et al. (1975) , who found a significantly lowered absorption of vitamin Be from a natural food source in a group of alcoholic patients with liver disease. The present findings, therefore, appear to agree with those of Shane and Contractor (1975) , who, in a study of pregnant women and oral contraceptive users, concluded that the red blood cell AST activation test appeared to be a poor indicator of vitamin Be status except in pronounced deficiency, as it is less responsive to vitamin depletion than blood pyridoxal phosphate levels. A similar lack of sensitivity of the red blood cell AST activation test in detecting vitamin Be deficiency seems to apply to the present population with alcohol-related illness. One of the most consistent findings in the present series is that of deficiency of the other water-soluble vitamin, vitamin C, the incidence being 91 % (32 of 35 cases). This finding is in agreement with the results of O' Keane et al. (1972) , who showed a significantly lower (p < 0'()()()5) mean leucocyte ascorbic acid level in 50 chronic alcoholics as compared with a matched control group. The above authors were also able to link the observed deficiency with diet, demonstrating a strong correlation between dietary intake of vitamin C and the leucocyte ascorbic acid level in the alcoholic and the control groups. As vitamin C is concerned with many metabolic processes, including collagen synthesis, corticosteroid and cholesterol metabolism, and electron transport processes, and requirement may be increased in liver disease to compensate for diminished storage and to allow tissue repair, it seems a prudent step to measure and, if necessary, correct the vitamin C status of patients admitted to care for problems associated with alcohol consumption. This may be easily achieved with intramuscular vitamin supplementation, a 10-day course of such a preparation (Parentrovite IMHP) restoring the leucocyte vitamin C level to 209 nmol/IO" WBC from an initial 42 nmol/10 s WBC in patient LT, no. 16.
The range of values for y-glutamyl transferase (y-GT) activity of the patients when seen was 27 VII to 2565 VII (Table 3) , with only three patients (9 %) below the upper limit of normal for their sex. Rosalki and Rau (1972) , in a study of 76 anicteric patients who were classified as either 'alcoholics' or 'heavy drinkers', found an incidence of elevation of the y-GT activity of 75 %. No enzyme other than y-GT was elevated in the group classified as heavy drinkers, which leads Rosalki and Rau to consider the measurement of y-GT to be a sensitive and highly specific test for the detection of liver cell injury in the suspected alcoholic. This link between alcohol exposure and elevation of y-GT has been confirmed by many other authors, for example, Rollason et al. (1972) were able to show an increasing incidence of elevation of y-GT with increased alcohol consumption in five groups of individuals imbibing differing amounts of alcohol. The purpose of the measurement of y-GT in the present work was to provide an indication of the degree of exposure to alcohol, and to determine if any correlation could be made between the elevation of y-GT and the degree of vitamin deficiency, possibly allowing a predictive statement of need for vitamin supplementation for a given y-GT activity. The results presented in Table 3 do not appear to suggest any constant correlation between y-GT activity and the vitamin deficiency. Thus patient TS, no. 24, who shows the highest y-GT activity (2565 Ujl), does indeed have deficiency of vitamins Bi, Bs, and C, but patient VS, no. 12, with a y-GT activity of 1665 VII, has deficiency of vitamin C only. Further, patients MK, no. 3, and LT, no. 16, with y-GT levels of 41 VII and 167 VII respectively, have deficiency in vitamins Br, Bs, and C, but patients JH, no. 23, and MA, no. 30, with jrGT levels of 648 VII and 266 VII, have deficiency of vitamin C only. The conclusion must be made, therefore, that the observed vitamin deficiency is not simply a factor of degree of exposure to alcohol but is probably dependent to a large extent on the dietary habits of the individual patient. It seems that a continued food intake, even in the face of sustained alcohol abuse, is able to maintain vitamin stores in some patients.
It can be concluded, therefore, that the patient admitted to hospital for problems associated with alcohol abuse is at risk of having developed a vitamin deficiency, that risk being a function of factors such as a degree of exposure to alcohol and dietary adequacy. The vitamin most commonly deficient is vitamin C, followed by vitamins Bi and Bs, but the actual incidence of deficiency is dependent upon the method of detection. The pyruvate response to glucose load, although more time-consuming than the red blood cell transketolase activation test, does appear to be more sensitive in detecting vitamin Bl deficiency. in the population under study, and its attractiveness, both to the investigator and to the patient, might be increased by reducing the number of samples to two, a fasting specimen and a 60minute sample following a glucose dose. The simple sample requirement of the red blood cell enzyme activation tests make them a useful adjunct to the pyruvate test and the leucocyte vitamin C estimation, but the limitations of the transketolase and aspartate transaminase estimations must be borne in mind. Indeed, with such a low incidence of vitamin B8 deficiency seen in this laboratory with the present method, it is doubtful whether the continued use of this method is justified. Finally, while the level of activity of y-GT gives a useful guide to alcohol exposure in the patient, it is not able to predict vitamin deficiency. Only an accurate dietary history, together with the biochemical tests described above, will identify those patients who would benefit from vitamin supplementation. I thank Mr G. Davies, principal biochemist, for help and advice with this work, the staff of the biochemistry laboratory for performing some of the estimations, the physicians of Broadgreen Hospital for access to patients in their care, and H. J. Crispe for typing the manuscript.
